The Role of Follicular Flushing at Oocyte Retrieval
FOFLOR
1 other identifier
interventional
75
1 country
2
Brief Summary
In vitro fertilization (IVF) is the most common method of medically assisted reproduction, involving fertilization of the egg by sperm in a lab. The process includes ovarian stimulation, oocyte retrieval, fertilization and culture, and embryo transfer. The success of IVF depends mainly on female age-as age increases, ovarian reserve and oocyte quality decrease-and the number of oocytes retrieved. This study investigates whether follicular flushing during oocyte retrieval can increase the number of mature oocytes retrieved. This randomized study will be conducted in women undergoing ovarian stimulation with recombinant Folicullar Stimulating Hormone (FSH) and Gonadotropin-Releasing Hormone (GnRH) antagonist or Progestin Primed Ovarian Stimulation (PPOS) to suppress premature Luteinizing hormone (LH) rise. Final oocyte maturation will be triggered with recombinant Human chorionic gonadotropin (hCG) or GnRH agonist. Eligible participants will have at least one follicle ≥11 mm in each ovary. On the day of oocyte retrieval, one ovary will be randomized to undergo follicular flushing using a single-lumen needle and the other simple aspiration, using the same needle. All fertilized oocytes from both ovaries will be cultured, seperately, to the blastocyst stage. Study outcomes are the number of oocytes and mature oocytes retrieved, the oocyte retrieval rate, the mature oocyte retrieval rate, the maturation rate, the number of fertilized oocytes, the fertilisation rate, the number of blastocytes and the blastulation rate. Sample size of 75 patients (25 per response category: poor, normal, high) provides 82-98% power to detect clinically meaningful interaction effects (Cohen's f=0.19-0.34) between response category and technique (follicular flushing vs. simple aspiration) under conservative assumptions of 50-70% of pilot study effects, lower correlations (ρ=0.35), and increased variability (α=0.05, two-sided, 5% attrition buffer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2026
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2025
CompletedFirst Posted
Study publicly available on registry
January 12, 2026
CompletedStudy Start
First participant enrolled
January 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 20, 2029
January 13, 2026
January 1, 2026
2 years
November 17, 2025
January 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of oocytes retrieved
Oocytes retrieved at oocyte retrieval are collected in the laboratory
Day 0
Secondary Outcomes (8)
Number of mature oocytes retrieved
Day 0
Oocyte retrieval rate
Day 0
Mature oocyte retrieval rate
Day 0
Rate of mature oocytes / total number of oocytes retrieved
Day 0
Number of fertilized oocytes
Day 1
- +3 more secondary outcomes
Study Arms (2)
Follicular flushing
ACTIVE COMPARATORFollicular flushing
Simple aspiration
ACTIVE COMPARATORSimple aspiration
Interventions
Simple aspiration in IVF is the technique used during oocyte retrieval to retrieve the oocytes from the ovaries.
Follicular flushing in IVF is a technique used during oocyte retrieval with the aim to increase the number of oocytes retrieved. In follicular flushing, after the initial aspiration, the follicle is rinsed (flushed) with a sterile fluid using the same needle. In the first arm, follicular flushing will be performed in the left ovary.
Eligibility Criteria
You may qualify if:
- Ovarian stimulation with recFSH and GnRH antagonist or PPOS protocol
- Triggering final oocyte maturation with hCG or GnRH agonist
- The day of oocyte retrieval at least one follicle of mean diameter of 11mm in each ovary
- ICSI method of fertilisation.
You may not qualify if:
- Presence of ovarian cyst of endometriosis
- History of ovarian surgery
- Monofollicular growth
- Presence of only one ovary
- Ovary not accessible at oocyte retrieval
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Eugonia IVF
Athens, Greece
Aristotle University of Thessaloniki
Thessaloniki, Greece
Related Publications (1)
Lainas GT, Lainas TG, Makris AA, Xenariou MV, Petsas GK, Kolibianakis EM. Follicular flushing increases the number of oocytes retrieved: a randomized controlled trial. Hum Reprod. 2023 Oct 3;38(10):1927-1937. doi: 10.1093/humrep/dead169.
PMID: 37632249BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Efstratios Kolibianakis, Professor
Unit of Human Reproduction, Aristotle University of Thessaloniki
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor in Obstetrics and Gynecology and Assisted Reproduction
Study Record Dates
First Submitted
November 17, 2025
First Posted
January 12, 2026
Study Start
January 14, 2026
Primary Completion (Estimated)
January 15, 2028
Study Completion (Estimated)
January 20, 2029
Last Updated
January 13, 2026
Record last verified: 2026-01